然而，同样的知识虽能帮助研究人员描绘疫苗靶标，但原则上也可能帮助威胁行为者填补自身理解中的空白。DeepMind 和 Isomorphic 将此描述为双重使命：推动前沿 AI 所实现的科学进步，同时防止这些工具落入会滥用它们的人手中。
据两家公司介绍，该计划基于三大支柱：防止滥用、更快地检测疫情，以及在疫情或攻击发生后进行应对。
过去一年建立的 15 个以上合作关系涵盖了这三大支柱，尽管更新中对涉及的组织只提供了有限细节，仅列出少数已命名的合作伙伴，包括劳伦斯利弗莫尔国家实验室（Lawrence Livermore National Laboratory）、英国 AI 安全研究所（UK AI Security Institute）、CEPI 和弗朗西斯·克里克研究所（Francis Crick Institute）。
DeepMind 表示，其计划在未来六到十二个月扩大这些合作关系，重点将转向威胁情报、AI 代理的评估方法以及越狱防护措施。它还与前沿模型论坛（Frontier Model Forum）就如何处理更高风险类别的训练数据进行协调，给出的例子是病毒学数据集。
Isomorphic Labs 更进一步，设立了专门部门，旨在在新型疫情爆发时迅速部署其药物设计引擎，与政府及国家研究机构（例如劳伦斯利弗莫尔、英国 AI 安全研究所、CEPI 和 Francis Crick 研究所）协作。该公司还承诺向菲律宾亚洲联盟项目“健康与人类潜能”（Health for Human Potential）捐赠 700 万美元，用于亚洲的传染病研究。
另见：Neko Health 融资 7 亿美元以扩大美国 AI 身体扫描业务：https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us/
想了解行业领导者关于 AI 和大数据的更多信息吗？请查看 AI & Big Data Expo：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，该展会将在阿姆斯特丹、加州和伦敦举行。该综合活动是 TechEx 的一部分：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，并与其他领先技术活动共同举办，包括 Cyber Security & Cloud Expo：https://cybersecuritycloudexpo.com/?utm_source=CloudTech-News&utm_medium=Footer-banner&utm_campaign=world-series。点击这里了解更多信息：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。
AI News 由 TechForge Media 提供支持：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。在此探索其他即将到来的企业技术活动和网络研讨会：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。
Ryan Daws：https://www.artificialintelligence-news.com/news/author/ryan/
AI Business Strategy：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/，人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/，专题报道：https://www.artificialintelligence-news.com/categories/features/，金融 AI：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/，工作世界：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/
AI 实践：https://www.artificialintelligence-news.com/categories/ai-in-action/，AI 市场趋势：https://www.artificialintelligence-news.com/categories/inside-ai/ai-market-trends/，人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/，人类与 AI 的关系：https://www.artificialintelligence-news.com/categories/ai-and-us/human-ai-relationships/，AI 内部资讯：https://www.artificialintelligence-news.com/categories/inside-ai/，制造与工程 AI：https://www.artificialintelligence-news.com/categories/ai-in-action/manufacturing-engineering-ai/，物理 AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/
Google DeepMind：https://deepmind.google/ and Isomorphic Labs：https://www.isomorphiclabs.com/ outlined a bioresilience program to curb AI misuse in biology while aiding outbreak response.
The two organisations published an update on a joint initiative that began quietly and has now built out more than 15 partnerships with government bodies, biosecurity organisations, and research groups over the past 12 months.
The disclosure arrives with a specific framing problem attached. Frontier models such as Gemini carry an increasingly detailed grasp of biology, and DeepMind acknowledges that pairing these systems with specialised biology models, agents like its Antigravity platform, and third-party databases will only sharpen that capability further.
However, the same knowledge that helps a researcher map a vaccine target could, in principle, help a threat actor close gaps in their own understanding. DeepMind and Isomorphic describe this as a dual mandate: enable the scientific advances frontier AI makes possible, while keeping those same tools out of the hands of people who’d misuse them.
The program sits on three pillars, according to the companies: preventing misuse, detecting outbreaks faster, and responding once an outbreak or attack is underway.
The 15-plus partnerships built over the last year touch all three, though the update gives limited detail on which organisations are involved beyond a handful of named collaborators, including Lawrence Livermore National Laboratory, the UK AI Security Institute, CEPI, and the Francis Crick Institute.
DeepMind says it intends to widen these relationships over the next six to twelve months, with attention turning to threat intelligence, evaluation methods for AI agents, and jailbreak mitigations. It’s also coordinating with the Frontier Model Forum on questions such as how to handle riskier categories of training data, virology datasets being the example given.
The prevention work rests on threat modelling designed to identify which actors are most likely to attempt misuse and what bottlenecks currently stop them. DeepMind says it uses a mix of expert red-teaming and randomised controlled trials to judge whether Gemini could help someone clear those bottlenecks.
Post-training methods are meant to teach the model to refuse harmful queries while avoiding what the company calls over-refusal of legitimate science questions, a balance that’s proven difficult across the industry generally, not just for DeepMind. Classifiers and probes are deployed to flag risky activity in real time, and the company says it runs targeted log analysis to catch more subtle misuse patterns that automated filters might miss.
None of these mitigations is described as solved. DeepMind frames them as an ongoing process rather than a finished system, which matters for any enterprise or government body evaluating whether to rely on the safeguards as currently configured. A classifier tuned against known jailbreak patterns in a controlled evaluation doesn’t guarantee equivalent performance against novel attack methods surfacing in live use, and the company doesn’t claim otherwise.
One of the more concrete risks under exploration involves DNA synthesis. Companies within the International Gene Synthesis Consortium currently screen orders against lists of known harmful pathogens and toxins, paired with screening algorithms. DeepMind states plainly that this approach is starting to fray, because AI can now help design DNA sequences with similar function to a dangerous pathogen without matching its sequence closely enough to trigger existing screens.
The proposed fix borrows from DeepMind’s existing watermarking system, SynthID, which the company says has become an industry standard for marking AI-generated images and text. Adapting it to biological sequences is presented as exploratory work, not a shipped product.
A longer-term goal, described as an open technical challenge rather than something close to resolved, involves screening that predicts whether a novel DNA sequence is likely toxic or pathogenic based on its function, regardless of whether it resembles anything in existing databases.
Detection depends on metagenomic sequencing, which characterises every microorganism in a sample rather than checking for a shortlist of known pathogens the way traditional diagnostics do. The limiting factor is cost, and scaling the approach to the regions where outbreaks are most likely to originate requires that cost to fall considerably.
DeepMind points to a collaboration between Google and Pacific Biosciences：https://www.pacb.com/ that used its AlphaEvolve coding agent to improve sequencing accuracy as one data point toward that goal. The company says it’s now looking at further opportunities – from optimising the algorithms that process sequencing data, through to informing hardware design – and separately exploring whether AlphaGenome could help characterise pathogens directly from sequence data.
These remain research collaborations rather than field-deployed systems, and the distance between a sequencing accuracy gain in a controlled pipeline and a functioning early-warning network across wastewater and transit hubs in low-resource settings is not small.
The response pillar leans on the medical countermeasure gap that leaves many known pathogens without a licensed diagnostic, vaccine, or treatment. DeepMind cites more than 10,000 publications on infectious disease that have referenced AlphaFold over five years, covering work on tuberculosis and malaria transmission and target mapping for threats including Mpox and Nipah.
The newest addition to that record is a partnership with Lawrence Livermore’s bioresilience program, which plans to use AlphaFold 3 for broad-spectrum antibody design work, including a pan-filovirus antibody effort. DeepMind says it will keep adding protein structures and complexes to the AlphaFold Protein Structure Database this year, prioritising targets relevant to countermeasure development.
Access to newer agent systems, including Co-Scientist, is being extended to selected researchers, among them scientists in the US Department of Energy’s National Laboratories working under the Genesis Mission.
Isomorphic Labs has gone a step further, setting up a dedicated unit intended to deploy its drug design engine quickly during a novel outbreak, working alongside government and national research bodies such as Lawrence Livermore, the UK AI Security Institute, CEPI, and the Francis Crick Institute. The company also pledged $7 million to Health for Human Potential, a Philanthropy Asia Alliance programme, for infectious disease research across Asia.
DeepMind’s recommendations to US policymakers map directly onto its three pillars and lean on specific pending legislation:
None of that legislation is enacted, and the gap between a company’s policy wishlist and a functioning federal biosecurity framework is where the real test of this program will play out over the next 6-12 months.
See also: Neko Health raises $700 million to expand AI body scans in the US ：https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us/
Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series and is co-located with other leading technology events including the Cyber Security & Cloud Expo：https://cybersecuritycloudexpo.com/?utm_source=CloudTech-News&utm_medium=Footer-banner&utm_campaign=world-series. Click here：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series for more information.
AI News is powered by TechForge Media：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series. Explore other upcoming enterprise technology events and webinars here：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series.
Ryan Daws：https://www.artificialintelligence-news.com/news/author/ryan/
AI Business Strategy：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/, Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/, Features：https://www.artificialintelligence-news.com/categories/features/, Finance AI：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/, World of Work：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/
AI in Action：https://www.artificialintelligence-news.com/categories/ai-in-action/, AI Market Trends：https://www.artificialintelligence-news.com/categories/inside-ai/ai-market-trends/, Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/, Human-AI Relationships：https://www.artificialintelligence-news.com/categories/ai-and-us/human-ai-relationships/, Inside AI：https://www.artificialintelligence-news.com/categories/inside-ai/, Manufacturing & Engineering AI：https://www.artificialintelligence-news.com/categories/ai-in-action/manufacturing-engineering-ai/, Physical AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/
扫码直达文章详情